Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease

• Главные авторы: Kelly N. Z. Fuller (Автор), Edwin R. Miranda (Автор), John P. Thyfault (Автор), Jill K. Morris (Автор), Jacob M. Haus (Автор)
• Формат: ‌
• Опубликовано: Hindawi Limited, 2018-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Although there is evidence for metabolic dysfunction and chronic inflammation in Alzheimer's disease (AD), circulating levels of soluble receptor for advanced glycation end products (sRAGE) and the receptor for advanced glycation end products (RAGE) ligand S100B have not been characterized. sRA...